Primary non-response, secondary loss of response, and treatment-limiting adverse events (AEs) continue to affect substantial proportions of patients
Applied together, they can destabilize each other and cause irritation that neither would cause alone
Differences in blood sugar control For people with type 2 diabetes, tirzepatide also showed better results for improving blood sugar levels: In a head-to-head trial directly comparing the two medications, tirzepatide (15mg dose) reduced A1C by about 2.3 percentage points, while semaglutide (1mg dose) reduced it by 1.86 points an additional 0.45% reduction with tirzepatide
However, the Department of Health and Social Care recommends that you should not take an excessive amount, as this could be harmful
Biochim Biophys Acta BBA-Gen Subj 839(1):6270
TB-500 works systemically